logo

For the Inventor, By the Inventor

Irvine, CA, United States of America

Edward Hsia

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Allergan, Inc.. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward Hsia. Retrieved from https://idiyas.com/inventor/edward-hsia-pbuhsgzw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal5 out of 2,287 
 
Allergan, Inc.
 patents

Years Active: 2016-2020

Loading Chart...
5 patents (USPTO):Explore Patents
1. 10799518 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases (2020-10-13),
2. 10434112 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases (2019-10-08),
3. 10201535 - Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions (2019-02-12),
4. 9308201 - Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions (2016-04-12),
5. 9283217 - Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions (2016-03-15),

Title: The Innovations of Edward Hsia

Introduction

Edward Hsia is a notable inventor based in Irvine, California. He has made significant contributions to the field of dermatology through his innovative research and development. With a total of five patents to his name, Hsia's work focuses on advancing treatments for dermatological diseases.

Latest Patents

One of Hsia's latest patents is titled "Use of agonists of formyl peptide receptor 2 for treating dermatological diseases." This invention relates to a method for treating dermal inflammation and dermal diseases by local or systemic delivery. The method involves administering a pharmaceutical composition that contains a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2 (FPR2). This innovative approach aims to provide effective treatment options for individuals suffering from various skin conditions.

Career Highlights

Edward Hsia is currently associated with Allergan, Inc., a leading company in the pharmaceutical industry. His work at Allergan has allowed him to focus on developing groundbreaking treatments that address unmet medical needs in dermatology. Hsia's dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Hsia has collaborated with several talented individuals in his career, including John E Donello and Mohammed I Dibas. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Edward Hsia's contributions to dermatological research and innovation are noteworthy. His patents reflect a commitment to improving treatment options for patients with skin diseases. Through his work at Allergan, Hsia continues to make a significant impact in the field of dermatology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…